Carlomagno F - Search Results

1

Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer.

Carlomagno F, Chang-Claude J, Dunning AM, Ponder BA. Carlomagno F, et al. Genes Chromosomes Cancer. 1999 Aug;25(4):393-5. doi: 10.1002/(sici)1098-2264(199908)25:4<393::aid-gcc12>3.0.co;2-8. Genes Chromosomes Cancer. 1999. PMID: 10398434

2

Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities.

Carlomagno F, Burnet NG, Turesson I, Nyman J, Peacock JH, Dunning AM, Ponder BA, Jackson SP. Carlomagno F, et al. Int J Cancer. 2000 Mar 15;85(6):845-9. doi: 10.1002/(sici)1097-0215(20000315)85:6<845::aid-ijc18>3.0.co;2-c. Int J Cancer. 2000. PMID: 10709106 Free article.

3

The extent of linkage disequilibrium in four populations with distinct demographic histories.

Dunning AM, Durocher F, Healey CS, Teare MD, McBride SE, Carlomagno F, Xu CF, Dawson E, Rhodes S, Ueda S, Lai E, Luben RN, Van Rensburg EJ, Mannermaa A, Kataja V, Rennart G, Dunham I, Purvis I, Easton D, Ponder BA. Dunning AM, et al. Among authors: carlomagno f. Am J Hum Genet. 2000 Dec;67(6):1544-54. doi: 10.1086/316906. Epub 2000 Nov 14. Am J Hum Genet. 2000. PMID: 11078480 Free PMC article.

4

Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.

Santoro M, Sabino N, Ishizaka Y, Ushijima T, Carlomagno F, Cerrato A, Grieco M, Battaglia C, Martelli ML, Paulin C, et al. Santoro M, et al. Among authors: carlomagno f. Br J Cancer. 1993 Sep;68(3):460-4. doi: 10.1038/bjc.1993.370. Br J Cancer. 1993. PMID: 8353035 Free PMC article.

5

Central role of RET in thyroid cancer.

Santoro M, Carlomagno F. Santoro M, et al. Among authors: carlomagno f. Cold Spring Harb Perspect Biol. 2013 Dec 1;5(12):a009233. doi: 10.1101/cshperspect.a009233. Cold Spring Harb Perspect Biol. 2013. PMID: 24296167 Free PMC article. Review.

6

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N, et al. Santoro M, et al. Among authors: carlomagno f. J Clin Invest. 1992 May;89(5):1517-22. doi: 10.1172/JCI115743. J Clin Invest. 1992. PMID: 1569189 Free PMC article.

7

Identification of RET kinase inhibitors as potential new treatment for sporadic and inherited thyroid cancer.

Carlomagno F, Santoro M. Carlomagno F, et al. J Chemother. 2004 Nov;16 Suppl 4:49-51. doi: 10.1179/joc.2004.16.Supplement-1.49. J Chemother. 2004. PMID: 15693160

8

Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells.

Santoro M, Battaglia C, Zhang L, Carlomagno F, Martelli ML, Salvatore D, Fusco A. Santoro M, et al. Among authors: carlomagno f. Exp Cell Res. 1994 Aug;213(2):398-403. doi: 10.1006/excr.1994.1215. Exp Cell Res. 1994. PMID: 8050496

9

The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes.

Carlomagno F, Vitagliano D, Guida T, Napolitano M, Vecchio G, Fusco A, Gazit A, Levitzki A, Santoro M. Carlomagno F, et al. Cancer Res. 2002 Feb 15;62(4):1077-82. Cancer Res. 2002. PMID: 11861385

10

Molecular mechanisms of RET activation in human cancer.

Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G. Santoro M, et al. Among authors: carlomagno f. Ann N Y Acad Sci. 2002 Jun;963:116-21. doi: 10.1111/j.1749-6632.2002.tb04102.x. Ann N Y Acad Sci. 2002. PMID: 12095936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page